1. Home
  2. CGON
  3. CGON News

Latest CG ONCOLOGY INC (CGON) News on May 29, 2024

CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual Meeting

GlobeNewswire

5 days ago

CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual Meeting

Business Wire

4 months ago

Form 8.3 - DX (Group) plc

Share on Social Networks: